Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Clinical trial NCT05709171 · UNKNOWN
Trial details
- NCT number
- NCT05709171
- Sponsor
- Rigshospitalet, Denmark
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-17
- Primary completion
- 2025-01-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.